Use of Ledipasvir/Sofosbuvir with or without Ribavirin in Patients Post-Liver Transplant: Evaluation of Real-World Datasets

被引：0
|
作者：
Flamm, S. [1 ]
Charlton, M. [2 ]
Manns, M. [3 ]
Prieto, M. [4 ]
Fernandez, I. [5 ]
Londono, M. [6 ]
Kwok, R. [7 ]
Smith, C. [8 ]
Lee, S. [9 ]
Ngo, H. [9 ]
Osinusi, A. [9 ]
Copans, A. [9 ]
Rossaro, L. [9 ]
Shoreibah, M. [10 ]
Massoud, O. [10 ]
Curry, M. [11 ]
Bourliere, M. [12 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Intermt Med Ctr, Murray, KY USA
[3] Hannover Med Sch, Hannover, Germany
[4] Hosp Univ I Politecn La Fe, Valencia, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Hosp Clin Barcelona, Serv Hepatol, Barcelona, Spain
[7] Walter Reed Natl Mil Med Ctr, Washington, DC USA
[8] Medstar Georgetown Univ Hosp, Georgetown, Guyana
[9] Gilead Sci Inc, Foster City, CA USA
[10] Univ Alabama Birmingham, Birmingham, AL USA
[11] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[12] Hosp St Joseph, Marsielle, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
145
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [41] Treatment Discontinuation, Adherence, and Real-World Effectiveness Among Patients Treated with Ledipasvir/Sofosbuvir in the United States
    Amy Puenpatom
    Michael Hull
    Jeffrey McPheeters
    Kay Schwebke
    Infectious Diseases and Therapy, 2017, 6 : 423 - 433
  • [42] Treatment Discontinuation, Adherence, and Real-World Effectiveness Among Patients Treated with Ledipasvir/Sofosbuvir in the United States
    Puenpatom, Amy
    Hull, Michael
    McPheeters, Jeffrey
    Schwebke, Kay
    INFECTIOUS DISEASES AND THERAPY, 2017, 6 (03) : 423 - 433
  • [43] Real-world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan
    Chen, Jyh-Jou
    Lee, Pei-Lun
    Chiu, Hung-Chih
    Tung, Hung-Da
    Chiu, Yen-Cheng
    Cheng, Pin-Nan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (03) : 467 - 472
  • [44] Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease
    Sinakos, E.
    Panas, P.
    Fragkou, N.
    Antoniadis, N.
    Katsanos, G.
    Tsakni, E.
    Oikonomou, T.
    Notopoulos, A.
    Tsoulfas, G.
    Goulis, I
    Akriviadis, E.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2022, 85 (02) : 331 - 337
  • [45] REAL-WORLD EXPERIENCE WITH LEDIPASVIR/SOFOSBUVIR COMBINATION AND SOFOSBUVIR/VELPATASVIR COMBINATOIN IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 6 PATIENTS IN THE UNITED STATES
    Nguyen, Emily
    Trinh, Sam
    Trinh, Huy N.
    Khanh Nguyen
    Levitt, Brian
    My Nguyen
    Purohit, Treta
    Shieh, Eugenie
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2018, 154 (06) : S1189 - S1189
  • [46] Real-world effectiveness and safety of Daclatasvir/Sofosbuvir with or without Ribavirin among genotype 5 and 6 Hepatitis C Virus patients
    Iwamoto, Momoko
    Sonderup, Mark W.
    Sann, Kimchamroeun
    Fortas, Camille
    Spearman, C. W.
    Dimanche, Chhit
    Kien, Antharo
    Peas, Muslim
    Hang, Vithurneat
    Unn, Keoputhika
    Shroufi, Amir
    Marquardt, Tonia
    Balkan, Suna
    Loarec, Anne
    Chikwanha, Isaac
    Le Paih, Michael
    Dousset, Jean-Philippe
    Maman, David
    HEPATOLOGY, 2017, 66 (06) : 1264A - 1265A
  • [47] Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir I Sofosbuvir Plus Ribavirin Pretransplant
    Yoshida, Eric M.
    Kwo, Paul
    Agarwal, Kosh
    Duvoux, Christophe
    Durand, Francois
    Peck-Radosavljevic, Markus
    Lilly, Leslie
    Willems, Bernard
    Vargas, Hugo
    Kumar, Princy
    Brown, Robert S., Jr.
    Horsmans, Yves
    De-Oertel, Shampa
    Arterburn, Sarah
    Dvory-Sobol, Hadas
    Brainard, Diana M.
    McHutchison, John G.
    Terrault, Norah
    Rizzetto, Mario
    Muellhaupt, Beat
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 375 - 381
  • [48] UTILIZATION OF DAA THERAPIES LEDIPASVIR/SOFOSBUVIR AND SOFOSBUVIR/VELPATASVIR IN PATIENTS WITH GENOTYPE 1 HCV: REAL-WORLD EXPERIENCE FROM THE TRIO NETWORK
    Tsai, Naoky
    Bacon, Bruce
    Curry, Michael
    Dieterich, Douglas T.
    Flamm, Steven L.
    Kowdley, Kris V.
    Milligan, Scott
    Younossi, Zobair M.
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2017, 152 (05) : S1091 - S1091
  • [49] Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
    Welzel, Tania M.
    Petersen, Joerg
    Herzer, Kerstin
    Ferenci, Peter
    Gschwantler, Michael
    Wedemeyer, Heiner
    Berg, Thomas
    Spengler, Ulrich
    Weiland, Ola
    van der Valk, Marc
    Rockstroh, Juergen
    Peck-Radosavljevic, Markus
    Zhao, Yue
    Jimenez-Exposito, Maria Jesus
    Zeuzem, Stefan
    GUT, 2016, 65 (11) : 1861 - 1870
  • [50] Autonomic nervous system evaluation in post-liver transplant patients.
    Rashed, H
    Ismail, MK
    Riely, CA
    Waters, B
    Vera, S
    Fleckenstein, J
    Alkeshen, M
    Abell, T
    GASTROENTEROLOGY, 2000, 118 (04) : A985 - A985
12345